vs
亚什兰（ASH）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是亚什兰的1.6倍（$603.8M vs $386.0M），Privia Health Group, Inc.净利率更高（0.6% vs -3.1%，领先3.7%），Privia Health Group, Inc.同比增速更快（25.8% vs -4.7%），过去两年Privia Health Group, Inc.的营收复合增速更高（19.6% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
ASH vs PRVA — 直观对比
营收规模更大
PRVA
是对方的1.6倍
$386.0M
营收增速更快
PRVA
高出30.5%
-4.7%
净利率更高
PRVA
高出3.7%
-3.1%
两年增速更快
PRVA
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $603.8M |
| 净利润 | $-12.0M | $3.7M |
| 毛利率 | 27.2% | 20.8% |
| 营业利润率 | -1.6% | 1.2% |
| 净利率 | -3.1% | 0.6% |
| 营收同比 | -4.7% | 25.8% |
| 净利润同比 | 92.7% | -27.4% |
| 每股收益（稀释后） | $-0.26 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHPRVA
| Q1 26 | — | $603.8M | ||
| Q4 25 | $386.0M | $541.2M | ||
| Q3 25 | $477.0M | $580.4M | ||
| Q2 25 | $463.0M | $521.2M | ||
| Q1 25 | $479.0M | $480.1M | ||
| Q4 24 | $405.0M | $460.9M | ||
| Q3 24 | $521.0M | $437.9M | ||
| Q2 24 | $544.0M | $422.3M |
净利润ASHPRVA
| Q1 26 | — | $3.7M | ||
| Q4 25 | $-12.0M | $9.2M | ||
| Q3 25 | $31.0M | $6.9M | ||
| Q2 25 | $-742.0M | $2.7M | ||
| Q1 25 | $31.0M | $4.2M | ||
| Q4 24 | $-165.0M | $4.4M | ||
| Q3 24 | $17.0M | $3.5M | ||
| Q2 24 | $6.0M | $3.5M |
毛利率ASHPRVA
| Q1 26 | — | 20.8% | ||
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 33.2% | — | ||
| Q2 24 | 34.2% | — |
营业利润率ASHPRVA
| Q1 26 | — | 1.2% | ||
| Q4 25 | -1.6% | 2.1% | ||
| Q3 25 | 12.8% | 2.5% | ||
| Q2 25 | -152.9% | 0.6% | ||
| Q1 25 | 10.6% | 1.1% | ||
| Q4 24 | -44.2% | 1.1% | ||
| Q3 24 | 6.1% | 1.3% | ||
| Q2 24 | -11.2% | 1.2% |
净利率ASHPRVA
| Q1 26 | — | 0.6% | ||
| Q4 25 | -3.1% | 1.7% | ||
| Q3 25 | 6.5% | 1.2% | ||
| Q2 25 | -160.3% | 0.5% | ||
| Q1 25 | 6.5% | 0.9% | ||
| Q4 24 | -40.7% | 1.0% | ||
| Q3 24 | 3.3% | 0.8% | ||
| Q2 24 | 1.1% | 0.8% |
每股收益（稀释后）ASHPRVA
| Q1 26 | — | $0.02 | ||
| Q4 25 | $-0.26 | $0.08 | ||
| Q3 25 | $0.83 | $0.05 | ||
| Q2 25 | $-16.21 | $0.02 | ||
| Q1 25 | $0.65 | $0.03 | ||
| Q4 24 | $-3.50 | $0.03 | ||
| Q3 24 | $0.34 | $0.03 | ||
| Q2 24 | $0.12 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $419.5M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $805.9M |
| 总资产 | $4.5B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHPRVA
| Q1 26 | — | $419.5M | ||
| Q4 25 | $304.0M | $479.7M | ||
| Q3 25 | $215.0M | $441.4M | ||
| Q2 25 | $207.0M | $390.1M | ||
| Q1 25 | $168.0M | $469.3M | ||
| Q4 24 | $219.0M | $491.1M | ||
| Q3 24 | $300.0M | $422.0M | ||
| Q2 24 | $399.0M | $387.4M |
总债务ASHPRVA
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
股东权益ASHPRVA
| Q1 26 | — | $805.9M | ||
| Q4 25 | $1.9B | $737.2M | ||
| Q3 25 | $1.9B | $709.1M | ||
| Q2 25 | $1.9B | $682.9M | ||
| Q1 25 | $2.6B | $659.4M | ||
| Q4 24 | $2.6B | $635.2M | ||
| Q3 24 | $2.9B | $614.9M | ||
| Q2 24 | $3.0B | $595.4M |
总资产ASHPRVA
| Q1 26 | — | $1.4B | ||
| Q4 25 | $4.5B | $1.4B | ||
| Q3 25 | $4.6B | $1.4B | ||
| Q2 25 | $4.6B | $1.3B | ||
| Q1 25 | $5.2B | $1.2B | ||
| Q4 24 | $5.2B | $1.1B | ||
| Q3 24 | $5.6B | $1.1B | ||
| Q2 24 | $5.7B | $1.1B |
负债/权益比ASHPRVA
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $-49.5M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | -13.33× |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHPRVA
| Q1 26 | — | $-49.5M | ||
| Q4 25 | $125.0M | $127.5M | ||
| Q3 25 | $40.0M | $52.0M | ||
| Q2 25 | $115.0M | $8.0M | ||
| Q1 25 | $9.0M | $-24.1M | ||
| Q4 24 | $-30.0M | $74.8M | ||
| Q3 24 | $80.0M | $33.2M | ||
| Q2 24 | $127.0M | $34.5M |
自由现金流ASHPRVA
| Q1 26 | — | — | ||
| Q4 25 | $111.0M | — | ||
| Q3 25 | $6.0M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $-12.0M | — | ||
| Q4 24 | $-53.0M | — | ||
| Q3 24 | $42.0M | — | ||
| Q2 24 | $98.0M | — |
自由现金流率ASHPRVA
| Q1 26 | — | — | ||
| Q4 25 | 28.8% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | -13.1% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 18.0% | — |
资本支出强度ASHPRVA
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 5.3% | — |
现金转化率ASHPRVA
| Q1 26 | — | -13.33× | ||
| Q4 25 | — | 13.93× | ||
| Q3 25 | 1.29× | 7.58× | ||
| Q2 25 | — | 2.97× | ||
| Q1 25 | 0.29× | -5.70× | ||
| Q4 24 | — | 17.00× | ||
| Q3 24 | 4.71× | 9.38× | ||
| Q2 24 | 21.17× | 9.94× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
PRVA
| FFS-patient care | $391.1M | 65% |
| Capitated revenue | $86.1M | 14% |
| Other | $75.0M | 12% |
| FFS-administrative services | $31.4M | 5% |
| Care management fees (PMPM) | $17.9M | 3% |
| Other revenue | $2.3M | 0% |
